13.67
price up icon7.85%   0.995
pre-market  プレマーケット:  13.38   -0.29   -2.12%
loading

Indivior Plc (INDV) 最新ニュース

pulisher
01:00 AM

Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference - GlobeNewswire Inc.

01:00 AM
pulisher
Jun 03, 2025

Indivior to delist from London Stock Exchange, maintain primary listing on Nasdaq - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Indivior PLC To Contact The Firm - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 02, 2025

Indivior’s exit comes as no surprise - The Times

Jun 02, 2025
pulisher
Jun 02, 2025

Levi & Korsinsky Notifies Indivior PLC Investors of a Class Action Lawsuit and Upcoming DeadlineINDV - ACCESS Newswire

Jun 02, 2025
pulisher
Jun 02, 2025

Opioid Use Disorder Market Projected to Witness Massive GrowthIndivior PLC, Alkermes plc - openPR.com

Jun 02, 2025
pulisher
Jun 02, 2025

Trending tickers: The latest investor updates on Tesla, Palantir, Sanofi, Babcock and Indivior - Yahoo

Jun 02, 2025
pulisher
Jun 02, 2025

Kalkine : Indivior’s Exit from London Exchange Impacts FTSE 100 Pharmaceutical Landscape - Kalkine Media

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior to delist from London Stock Exchangewill stay on Nasdaq - Insider Media Ltd

Jun 02, 2025
pulisher
Jun 02, 2025

Drug maker Indivior joins London Stock Exchange exodus, 2 Jun 2025 11:00 - Shares Magazine

Jun 02, 2025
pulisher
Jun 02, 2025

Kalkine : Indivior’s FTSE 100 Sector Shift: Delisting from London to Focus on Nasdaq Listing - Kalkine Media

Jun 02, 2025
pulisher
Jun 02, 2025

Kalkine: Indivior Exits London as FTSE 100 Firm Focuses on Nasdaq - Kalkine Media

Jun 02, 2025
pulisher
Jun 02, 2025

FTSE pharma giant joins London stock market exodus - The Telegraph

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior (INDV) Delists from London to Focus on U.S. Market - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior brings curtain down on turbulent 11-year run in London - Proactive financial news

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior drops London listing to focus on U.S. market By Investing.com - Investing.com Nigeria

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior To Delist From LSE To Better Align With US Focused Business - Nasdaq

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior to cancel secondary listing in London - Sharecast.com

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior Plans to Cancel London Listing After Moving Primary to US - Bloomberg

Jun 02, 2025
pulisher
Jun 02, 2025

Drug maker Indivior to abandon London stock market for the US - Yahoo

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior to Cancel London Stock Exchange Listing, Focuses on Nasdaq - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior to Cancel Secondary Listing on London Stock Exchange, Maintains Primary Nasdaq Listing | Indivior Stock News - paginasiete.bo

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior to delist from London Stock Exchange, maintain Nasdaq listing - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained | INDV Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained - Bluefield Daily Telegraph

Jun 02, 2025
pulisher
Jun 01, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 1, 2024 in Indivior PLC LawsuitINDV - ACCESS Newswire

Jun 01, 2025
pulisher
May 27, 2025

Indivior Announces Patrick Barry as Chief Commercial Officer - The Malaysian Reserve

May 27, 2025
pulisher
May 27, 2025

Indivior appoints Patrick Barry as Chief Commercial Officer By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

Indivior Announces Patrick Barry as Chief Commercial Officer | I - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Indivior appoints Patrick Barry as Chief Commercial Officer - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Indivior Announces Patrick Barry as Chief Commercial Officer | INDV Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Indivior PLC (INDV) Stock Analysis: A 30% Upside Potential Amidst Strong Buy Ratings - DirectorsTalk Interviews

May 27, 2025
pulisher
May 26, 2025

Investors in Indivior (LON:INDV) have seen solid returns of 156% over the past five years - Yahoo Finance

May 26, 2025
pulisher
May 23, 2025

How To Trade (INDV) - news.stocktradersdaily.com

May 23, 2025
pulisher
May 23, 2025

Indivior PLC (LON:INDV) Held Back By Insufficient Growth Even After Shares Climb 26% - simplywall.st

May 23, 2025
pulisher
May 21, 2025

Naloxone Market Projected To Witness Massive Growth, 2025-2032 - openPR.com

May 21, 2025
pulisher
May 16, 2025

Court of Appeal upholds representative action strike out in Wirral Council v Indivior/Reckitt, but claimant applies for permission to appeal to Supreme Court - stewartslaw.com

May 16, 2025
pulisher
May 15, 2025

Indivior PLC Aligns CEO Compensation with Long-Term Performance Goals - TipRanks

May 15, 2025
pulisher
May 14, 2025

Indivior to Participate in Upcoming Investor Events - StreetInsider

May 14, 2025
pulisher
May 13, 2025

Indivior to Participate in Upcoming Investor Events | INDV Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Indivior announces participation in investor conferences By Investing.com - Investing.com India

May 13, 2025
pulisher
May 13, 2025

Indivior to Engage with Investors at Key Healthcare Conferences - TipRanks

May 13, 2025
pulisher
May 13, 2025

Indivior to Participate in Upcoming Investor Events – Company Announcement - Financial Times

May 13, 2025
pulisher
May 13, 2025

Drug Addiction Treatment Market Projected To Witness Massive - openPR.com

May 13, 2025
pulisher
May 12, 2025

(INDV) Long Term Investment Analysis - news.stocktradersdaily.com

May 12, 2025
pulisher
May 12, 2025

Drug Abuse Treatment Market Grows Amid Rising Substance Abuse - openPR.com

May 12, 2025
pulisher
May 12, 2025

Indivior advances GABA-B PAM program for substance use disorders through IND-enabling studies - BioWorld MedTech

May 12, 2025
pulisher
May 12, 2025

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies - Yahoo

May 12, 2025
pulisher
May 10, 2025

Shareholders of Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your RightsINDV - ACCESS Newswire

May 10, 2025
$8.59
price down icon 1.38%
drug_manufacturers_specialty_generic RDY
$14.75
price up icon 0.61%
$124.52
price down icon 0.38%
drug_manufacturers_specialty_generic HCM
$15.30
price up icon 4.08%
$323.97
price down icon 0.07%
$17.52
price up icon 1.92%
大文字化:     |  ボリューム (24 時間):